Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06508996 · ClinicalTrials.gov registry record
Xpert Hepatitis-C Virus (HCV) Test on the GeneXpert Xpress System
A clinical trial, sponsored by Cepheid.
- Completed
- Registry status
- 1,012
- Enrollment target
NCT06508996: Completed study, sponsored by Cepheid.
NCT06508996 is a clinical trial that has completed, run by Cepheid. The registered enrollment target is 1,012 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06508996 has completed, sponsored by Cepheid.
- COMPLETED
- Registry status
- 1,012 participants
- Enrollment target
Study Summary
A multi-site prospective, all comers study that was conducted at geographically diverse locations in the United States.
Primary Outcome
Clinical performance comparing Xpert test to PIS (NAAT + Antibody status)
Interventions
- DIAGNOSTIC_TEST Xpert HCV
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,012 participants |
| Start Date | 2024-02-06 |
| Est. Completion | 2024-06-06 |
What the finished NCT06508996 record still lists
NCT06508996 is an observational study that tracks outcomes without assigning an intervention. Its 1,012 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Xpert HCV is the first listed.
NCT06508996 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06508996 about?
NCT06508996 is a clinical study titled "Xpert Hepatitis-C Virus (HCV) Test on the GeneXpert Xpress System". A multi-site prospective, all comers study that was conducted at geographically diverse locations in the United States.
What is the current status of trial NCT06508996?
This trial is currently completed. The enrollment target is 1,012 participants. The study started on 2024-02-06. Estimated completion is 2024-06-06.
What interventions are being tested in trial NCT06508996?
The interventions under investigation include: Xpert HCV (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06508996?
This trial is sponsored by Cepheid, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06146738 · 1,015 participants
The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
- NCT06608823 · 1,016 participants · NA
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
- NCT07191782 · 1,008 participants · NA
Examining the Efficacy of the PRAISE With Coaching Program
- NCT06549595 · 1,018 participants · Phase 3
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI